Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 859.84 billion as of June 12, 2026. Its market cap has increased by 67.35% in one year.

Market Cap

859.84B

Enterprise Value

837.14B

Revenue

3.13B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,910.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 859.84B, an increase of 1,710.42%. That is a compound annual growth rate of 13.24%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2026	859.84B	80.32%
Dec 30, 2025	476.83B	-15.13%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1.04T	-4.44%
Dec 29, 2022	1.09T	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	59.95T
Celltrion	38.02T
ALTEOGEN	18.05T
Samsung Epis Holdings	11.11T
Chong Kun Dang Pharmaceutical	932.87B
Pharmicell	881.27B
DongKook Pharmaceutical	854.40B
SD Biosensor	848.13B

Market Cap Rankings